Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

BACKGROUND: We assessed the robustness of passive scattering proton therapy (PSPT) plans for patients in a phase II trial of PSPT for stage III non-small cell lung cancer (NSCLC) by using the worst-case scenario method, and compared the worst-case dose distributions with the appearance of locally re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhu, Zhengfei, Liu, Wei, Gillin, Michael, Gomez, Daniel R, Komaki, Ritsuko, Cox, James D, Mohan, Radhe, Chang, Joe Y
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029832/
https://ncbi.nlm.nih.gov/pubmed/24886059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-9-108
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados